阳性气道压力与药物坚持之间的相关性:健康用户的影响
Matthew J Lettieri1, Whittney A Warren2, Robert J Walter2,3
1Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania.
概括
患者对阻塞性睡眠呼吸暂停的阳性气道压力 (PAP) 治疗的坚持与他们的整体药物坚持有关. 改善药物服药可能会提高PAP治疗的有效性,以获得更好的健康结果.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统医学 呼吸系统医学
- 行为医学是一种行为医学.
背景情况:
- 阳性气道压力 (PAP) 对阻塞性睡眠呼吸暂停 (OSA) 有效,但坚持是个挑战.
- 目前尚不清楚PAP的不良坚持是否源于不耐受或一般不遵守医疗治疗.
研究的目的:
- 为了将阳性气道压力 (PAP) 使用与OSA患者的药物坚持相关联.
- 为了确定PAP的不良坚持是治疗的特异性还是反映了全球医疗合规性.
主要方法:
- 600名接受PAP治疗的OSA患者的客观PAP使用与药物坚持相关.
- 慢性药物 (使用≥90天) 通过电子健康记录进行验证.
- PAP的坚持:每晚≥70%的夜晚≥4小时;药物坚持:按处方服用的药丸>70%.
主要成果:
- 566名患者有完整的病历记录;361人 (63.8%) 使用慢性药物.
- 坚持药物治疗的患者使用PAP更多的小时/夜 (5.4比4.6,P<.001).
- 坚持患者更有可能实现定期使用PAP (P = .04).
结论:
- 阳性气道压力 (PAP) 坚持与坚持慢性药物相关.
- 低PAP坚持可能表明一个人的整体遵守医疗护理.
- 这种关联可以帮助识别需要针对性干预的患者,以改善医疗执法.
相关概念视频
Factors Affecting Pulmonary Ventilation
1.4K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.4K
Inhaled Medications
258
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
258
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
Antiasthma Drugs: Methylxanthines
228
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
228
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


